The Glycopeptide PV-PS A1 Immunogen Elicits Both CD4+ and CD8+ Responses
This study confirms PV-PS A1 as a robust MHCI- and MHCII-dependent carrier. This is the first report of MHCI dependence in a zwitterionic polysaccharide.
Authors
- Shanika Gamage
- Farzana Hossain (ORCID: https://orcid.org/0000-0001-7540-9765)
- Katherine A. Wall (ORCID: https://orcid.org/0000-0002-1150-4736)
- Sharmeen Nishat
- Geraud Valentin (ORCID: https://orcid.org/0009-0003-9414-8099)
- Peter R. Andreana (ORCID: https://orcid.org/0000-0002-5300-6700)
- Md Kamal Hossain
Institutions
- Bangladesh University of Engineering and Technology (BD)
- University of Toledo (US)
Publication Details
- Journal
- Vaccines
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3390/vaccines12121375
- Citations
- 2
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- University of Toledo
- National Cancer Institute